Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Brown

Showing results (261-270 of 327) with videos related to

Pageof 33
Sort By:
Frontiers in Microbiology|November 30, 2011
Protective antigens against glanders identified by expression library immunizationGregory C Whitlock, Mark D Robida, Barbara M Judy, et al.
Cancer Research|February 26, 2015
PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic TargetsMarzia Scortegagna, Eric Lau, Tongwu Zhang, et al.
Archives of Disease in Childhood|November 11, 2020
Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort studyThomas Waterfield, Chris Watson, Rebecca Moore, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 5, 2021
Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020Anna Jeffery-Smith, Nalini Iyanger, Sarah V Williams, et al.
JCI Insight|August 30, 2022
DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotypeAdriana Sanna, Bengt Phung, Shamik Mitra, et al.
Journal of Medicinal Chemistry|July 25, 2014
Structure-activity relationship studies and discovery of a potent transient receptor potential vanilloid (TRPV1) antagonist 4-[3-chloro-5-[(1S)-1,2-dihydroxyethyl]-2-pyridyl]-N-[5-(trifluoromethyl)-2-pyridyl]-3,6-dihydro-2H-pyridine-1-carboxamide (V116517) as a clinical candidate for pain managementLaykea Tafesse, Toshiyuki Kanemasa, Noriyuki Kurose, et al.
Biorxiv : the Preprint Server for Biology|July 2, 2020
CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2Razie Amraei, Wenqing Yin, Marc A Napoleon, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 7, 2025
Tick-borne encephalitis: from tick surveillance to the first confirmed human cases, the United Kingdom, 2015 to 2023Helen Callaby, Kate R Beard, Dominic Wakerley, et al.
Cell Reports|September 21, 2018
Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of ColitisYu Fujita, Ali Khateb, Yan Li, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a DecadeJiayu Yang, Lin Yang, Bryan Tordon, et al.
Pageof 33

Showing results (261-270 of 327) with videos related to

Sort By:
Pageof 33
Frontiers in Microbiology|November 30, 2011
Protective antigens against glanders identified by expression library immunizationGregory C Whitlock, Mark D Robida, Barbara M Judy, et al.
Cancer Research|February 26, 2015
PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic TargetsMarzia Scortegagna, Eric Lau, Tongwu Zhang, et al.
Archives of Disease in Childhood|November 11, 2020
Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort studyThomas Waterfield, Chris Watson, Rebecca Moore, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 5, 2021
Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020Anna Jeffery-Smith, Nalini Iyanger, Sarah V Williams, et al.
JCI Insight|August 30, 2022
DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotypeAdriana Sanna, Bengt Phung, Shamik Mitra, et al.
Journal of Medicinal Chemistry|July 25, 2014
Structure-activity relationship studies and discovery of a potent transient receptor potential vanilloid (TRPV1) antagonist 4-[3-chloro-5-[(1S)-1,2-dihydroxyethyl]-2-pyridyl]-N-[5-(trifluoromethyl)-2-pyridyl]-3,6-dihydro-2H-pyridine-1-carboxamide (V116517) as a clinical candidate for pain managementLaykea Tafesse, Toshiyuki Kanemasa, Noriyuki Kurose, et al.
Biorxiv : the Preprint Server for Biology|July 2, 2020
CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2Razie Amraei, Wenqing Yin, Marc A Napoleon, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 7, 2025
Tick-borne encephalitis: from tick surveillance to the first confirmed human cases, the United Kingdom, 2015 to 2023Helen Callaby, Kate R Beard, Dominic Wakerley, et al.
Cell Reports|September 21, 2018
Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of ColitisYu Fujita, Ali Khateb, Yan Li, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a DecadeJiayu Yang, Lin Yang, Bryan Tordon, et al.
Pageof 33